Timing of staples and dressing removal after cesarean delivery (the SCARR study).


Journal

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
ISSN: 1879-3479
Titre abrégé: Int J Gynaecol Obstet
Pays: United States
ID NLM: 0210174

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 19 03 2018
revised: 25 09 2018
accepted: 21 12 2018
pubmed: 26 12 2018
medline: 8 3 2019
entrez: 25 12 2018
Statut: ppublish

Résumé

To investigate optimal timing of dressing and staples removal after cesarean delivery (CD). This prospective clustered clinical trial enrolled women undergoing CD between January 1, 2013, and October 31, 2014, at Hadassah-Hebrew University Hospital, Jerusalem. Women were assigned to one of five clusters differing in timing of dressing and staples removal. We assessed scar healing at 6 weeks. 920 women completed telephone questionnaires. Wound healing did not differ significantly among the clusters: the healing complication rate was 21% in the control group (n=46) and ranged from 18% to 26% (n=27-50) in clusters two to five (P=0.49). More healing complications were observed in women with a body mass index (BMI) of more than 35 kg/m Timing of dressing and staples removal has no effect on CD scar healing in low- and high-risk parturients. A BMI of more than 35 kg/m

Identifiants

pubmed: 30582610
doi: 10.1002/ijgo.12757
doi:

Banques de données

ClinicalTrials.gov
['NCT01724255']

Types de publication

Clinical Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

283-289

Informations de copyright

© 2018 International Federation of Gynecology and Obstetrics.

Auteurs

Netanella Heinemann (N)

Department of Obstetrics and Gynecology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.

Amy Solnica (A)

Department of Obstetrics and Gynecology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.

Rana Abdelkader (R)

Department of Obstetrics and Gynecology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.

Jakov Gutman (J)

Department of Obstetrics and Gynecology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.

Noemzar Nalbandian (N)

Department of Nursing Administration, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.

Ela Raizman (E)

Department of Nursing Administration, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.

Drorith Hochner-Celnikier (D)

Department of Obstetrics and Gynecology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH